Literature DB >> 25257913

Image-based evaluation of contraction-relaxation kinetics of human-induced pluripotent stem cell-derived cardiomyocytes: Correlation and complementarity with extracellular electrophysiology.

Tomohiro Hayakawa1, Takeshi Kunihiro2, Tomoko Ando3, Seiji Kobayashi2, Eriko Matsui2, Hiroaki Yada2, Yasunari Kanda3, Junko Kurokawa3, Tetsushi Furukawa4.   

Abstract

In this study, we used high-speed video microscopy with motion vector analysis to investigate the contractile characteristics of hiPS-CM monolayer, in addition to further characterizing the motion with extracellular field potential (FP), traction force and the Ca(2+) transient. Results of our traction force microscopy demonstrated that the force development of hiPS-CMs correlated well with the cellular deformation detected by the video microscopy with motion vector analysis. In the presence of verapamil and isoproterenol, contractile motion of hiPS-CMs showed alteration in accordance with the changes in fluorescence peak of the Ca(2+) transient, i.e., upstroke, decay, amplitude and full-width at half-maximum. Simultaneously recorded hiPS-CM motion and FP showed that there was a linear correlation between changes in the motion and field potential duration in response to verapamil (30-150nM), isoproterenol (0.1-10μM) and E-4031 (10-50nM). In addition, tetrodotoxin (3-30μM)-induced delay of sodium current was corresponded with the delay of the contraction onset of hiPS-CMs. These results indicate that the electrophysiological and functional behaviors of hiPS-CMs are quantitatively reflected in the contractile motion detected by this image-based technique. In the presence of 100nM E-4031, the occurrence of early after-depolarization-like negative deflection in FP was also detected in the hiPS-CM motion as a characteristic two-step relaxation pattern. These findings offer insights into the interpretation of the motion kinetics of the hiPS-CMs, and are relevant for understanding electrical and mechanical relationship in hiPS-CMs.
Copyright © 2014. Published by Elsevier Ltd.

Entities:  

Keywords:  Ca(2+) transient; Field potential; Human-induced pluripotent stem cell-derived cardiomyocytes; Motion vector prediction; Multi-electrode arrays; Traction force microscopy

Mesh:

Substances:

Year:  2014        PMID: 25257913     DOI: 10.1016/j.yjmcc.2014.09.010

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  49 in total

1.  A Premature Termination Codon Mutation in MYBPC3 Causes Hypertrophic Cardiomyopathy via Chronic Activation of Nonsense-Mediated Decay.

Authors:  Timon Seeger; Rajani Shrestha; Chi Keung Lam; Caressa Chen; Wesley L McKeithan; Edward Lau; Alexa Wnorowski; George McMullen; Matthew Greenhaw; Jaecheol Lee; Angelos Oikonomopoulos; Soah Lee; Huaxiao Yang; Mark Mercola; Matthew Wheeler; Euan A Ashley; Fan Yang; Ioannis Karakikes; Joseph C Wu
Journal:  Circulation       Date:  2019-02-05       Impact factor: 29.690

2.  Diffraction-based technology for the monitoring of contraction dynamics in 3D and 2D tissue models.

Authors:  Ronan Le Harzic; Ina Meiser; Julia C Neubauer; Iris Riemann; Michael Schiffer; Frank Stracke; Heiko Zimmermann
Journal:  Biomed Opt Express       Date:  2020-01-02       Impact factor: 3.732

3.  Assessing Drug-Induced Long QT and Proarrhythmic Risk Using Human Stem-Cell-Derived Cardiomyocytes in a Ca2+ Imaging Assay: Evaluation of 28 CiPA Compounds at Three Test Sites.

Authors:  Hua Rong Lu; Haoyu Zeng; Ralf Kettenhofen; Liang Guo; Ivan Kopljar; Karel van Ammel; Fetene Tekle; Ard Teisman; Jin Zhai; Holly Clouse; Jennifer Pierson; Michael Furniss; Armando Lagrutta; Frederick Sannajust; David J Gallacher
Journal:  Toxicol Sci       Date:  2019-08-01       Impact factor: 4.849

4.  SETD7 Drives Cardiac Lineage Commitment through Stage-Specific Transcriptional Activation.

Authors:  Jaecheol Lee; Ning-Yi Shao; David T Paik; Haodi Wu; Hongchao Guo; Vittavat Termglinchan; Jared M Churko; Youngkyun Kim; Tomoya Kitani; Ming-Tao Zhao; Yue Zhang; Kitchener D Wilson; Ioannis Karakikes; Michael P Snyder; Joseph C Wu
Journal:  Cell Stem Cell       Date:  2018-03-01       Impact factor: 24.633

5.  Optophysiology of cardiomyocytes: characterizing cellular motion with quantitative phase imaging.

Authors:  Christine Cordeiro; Oscar J Abilez; Georges Goetz; Tushar Gupta; Yan Zhuge; Olav Solgaard; Daniel Palanker
Journal:  Biomed Opt Express       Date:  2017-09-22       Impact factor: 3.732

6.  Reflective lens-free imaging on high-density silicon microelectrode arrays for monitoring and evaluation of in vitro cardiac contractility.

Authors:  Thomas Pauwelyn; Richard Stahl; Lakyn Mayo; Xuan Zheng; Andy Lambrechts; Stefan Janssens; Liesbet Lagae; Veerle Reumers; Dries Braeken
Journal:  Biomed Opt Express       Date:  2018-03-22       Impact factor: 3.732

Review 7.  Using iPSC Models to Probe Regulation of Cardiac Ion Channel Function.

Authors:  Arne A N Bruyneel; Wesley L McKeithan; Dries A M Feyen; Mark Mercola
Journal:  Curr Cardiol Rep       Date:  2018-05-25       Impact factor: 2.931

8.  The effects of verapamil and its combinations with glutamate and glycine on cardiodynamics, coronary flow and oxidative stress in isolated rat heart.

Authors:  Isidora Stojic; Ivan Srejovic; Vladimir Zivkovic; Nevena Jeremic; Marko Djuric; Ana Stevanovic; Tamara Milanovic; Dragan Djuric; Vladimir Jakovljevic
Journal:  J Physiol Biochem       Date:  2016-11-03       Impact factor: 4.158

9.  Optical Method to Quantify Mechanical Contraction and Calcium Transients of Human Pluripotent Stem Cell-Derived Cardiomyocytes.

Authors:  Katrina J Hansen; John T Favreau; Joshua R Gershlak; Michael A Laflamme; Dirk R Albrecht; Glenn R Gaudette
Journal:  Tissue Eng Part C Methods       Date:  2017-06-27       Impact factor: 3.056

10.  Real-Time Force and Frequency Analysis of Engineered Human Heart Tissue Derived from Induced Pluripotent Stem Cells Using Magnetic Sensing.

Authors:  Kevin S Bielawski; Andrea Leonard; Shiv Bhandari; Chuck E Murry; Nathan J Sniadecki
Journal:  Tissue Eng Part C Methods       Date:  2016-09-28       Impact factor: 3.056

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.